1-1 of 1
Juan Zapata, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from a First-in-Human Study with Bnz-1: A Novel Peptide Inhibitor of IL-2, IL-9 and IL-15 for the Treatment of T-Cell Malignancies That Safely and Selectively Decreases Regulatory T-Cells, Natural Killer Cells, and CD8 + Central Memory T-Cells

Paul Frohna, MD PhD PharmD, Yutaka Tagaya, MD PhD, Anoshie Ratnayake, MD, Nick Doerr, PhD, Asjad Basheer, PhD, Laith Al-Mawsawi, Woo Jae Kim, PhD, Juan Zapata, PhD, Xisorong Wu, BS, Nazli Azimi, PhD PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 695.
https://doi.org/10.1182/blood.V130.Suppl_1.695.695
Published: 2017